We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current COLL market cap is 733.89M. The company's latest EPS is USD 2.1594 and P/E is 15.25.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 136.71M | 149.75M | 144.92M | 145.28M | 159.3M |
| Operating Income | 45.01M | 61.69M | 49.47M | 47.47M | 34.84M |
| Net Income | 20.63M | 31.94M | 27.71M | 19.61M | 9.34M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 296.7M | 310.02M | 276.87M | 463.93M | 566.77M |
| Operating Income | -23.75M | 56.23M | 17.63M | 33.32M | 166.96M |
| Net Income | -22.72M | 26.75M | 71.52M | -25M | 48.16M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 1.18B | 1.14B | 1.11B | 1.05B | 1.64B |
| Total Liabilities | 998.71M | 947.88M | 892.08M | 836.81M | 1.4B |
| Total Equity | 178.87M | 195.43M | 222.17M | 216.58M | 234.28M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 306.3M | 643.84M | 692.08M | 1.17B | 1.14B |
| Total Liabilities | 218.87M | 457.81M | 489.15M | 979.29M | 947.88M |
| Total Equity | 87.43M | 186.03M | 202.93M | 194.84M | 195.43M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 201.41M | 274.75M | 61.94M | 129.34M | 120.34M |
| Investing | -45.72M | -70.81M | -18.13M | -27.03M | -276M |
| Financing | -72.35M | -140.18M | -54.15M | -168.35M | -19.33M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 27.78M | 93.94M | 103.56M | 124.23M | 274.75M |
| Investing | -6.44M | -373.77M | -1.94M | -573.69M | -70.81M |
| Financing | 2.04M | 286.47M | -89.3M | 436.72M | -140.18M |
| Market Cap | 733.89M |
| Price to Earnings Ratio | 15.25 |
| Price to Sales Ratio | 1.3 |
| Price to Cash Ratio | 3.07 |
| Price to Book Ratio | 3.76 |
| Dividend Yield | - |
| Shares Outstanding | 22.3M |
| Average Volume (1 week) | 686.58k |
| Average Volume (1 Month) | 511.65k |
| 52 Week Change | 1.95% |
| 52 Week High | 42.23 |
| 52 Week Low | 28.39 |
| Spread (Intraday) | 1.87 (5.54%) |
| Company Name | Collegium Pharmaceutical Inc |
| Address |
100 shockoe slip richmond, virginia 23219 4100 |
| Website | https://www.collegiumpharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
